Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Wyeth-Ayerst and Neose Technologies enter R&D licensing agreement

Dec. 24, 2001

Daiichi patents new series of anticoagulants

Dec. 21, 2001

Aspirin and warfarin equieffective in the prevention of recurrent ischemic stroke

Dec. 21, 2001

Promoters of fibrinolysis designed at Torii as new antithrombotic drugs

Dec. 20, 2001

Approval recommended in E.U. for Arixtra

Dec. 19, 2001

Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent

Dec. 17, 2001

First human study demonstrates safety of heparin/SNAD and potential efficacy

Dec. 14, 2001

Successful repeated administration of MaxAdFVIII achieved in animal studies

Dec. 14, 2001

Replacement therapy for congenital protein C deficiency now available in Europe

Dec. 14, 2001

Arixtra receives FDA approval

Dec. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...